Transactions
Lotus Clinical Research recapitalized by DFW Capital Partners
Sep. 2018
Client: Lotus Clinical Research is the preeminent analgesic specialty clinical research organization (CRO)
Role: Edgemont Partners acted as exclusive financial advisor to Lotus Clinical Research in its recapitalization by DFW Capital
Location: Pasadena, CA
Sector: Pharmaceutical Services
Lead Banker: David Blume